Oral products with improved binding of active ingredients

US11793230B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11793230-B2
Application numberUS-201916707602-A
CountryUS
Kind codeB2
Filing dateDec 9, 2019
Priority dateDec 9, 2019
Publication dateOct 24, 2023
Grant dateOct 24, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The disclosure provides products configured for oral use, the products including compositions comprising a filler component including negatively charged groups and an active ingredient including positively charged groups. The active ingredient can be retained by the filler component at least in part through bonding between the negatively charged groups and the positively charged groups such that active ingredient may be release from the product when positioned within an oral cavity of a consumer.

First claim

Opening claim text (preview).

The invention claimed is: 1. An oral product comprising: an active ingredient comprising a positively charged group; and a filler which is carboxylated microcrystalline cellulose; wherein the active ingredient is retained by the filler through bonding of the positively charged group and the carboxylated microcrystalline cellulose, wherein the active ingredient is configured for release when the product is present in an oral cavity. 2. The product of claim 1 , wherein the active ingredient is selected from the group consisting of a nicotine component, botanicals, stimulants, amino acids, vitamins, cannabinoids, nutraceuticals, and combinations thereof. 3. The product of claim 1 , wherein the active ingredient comprises protonated nicotine. 4. The product of claim 1 , further comprising one or more flavoring agents. 5. The product of claim 4 , wherein the one or more flavoring agents comprises a compound having a carbon-carbon double bond, a carbon-oxygen double bond, or both. 6. The product of claim 5 , wherein the one or more flavoring agents comprises one or more aldehydes, ketones, esters, terpenes, terpenoids, trigeminal sensates, or a combination thereof. 7. The product of claim 5 , wherein the one or more flavoring agents comprises one or more of ethyl vanillin, cinnamaldehyde, sabinene, limonene, gamma-terpinene, beta-farnesene, and citral. 8. The product of claim 1 , wherein the filler is in a particulate form. 9. The product of claim 1 , wherein the product comprises no more than about 10% by weight of a tobacco material, excluding any nicotine component present, based on the total weight of the mixture. 10. The product of claim 1 , wherein at least the active ingredient and the filler are combined as a mixture that is enclosed in a pouch to form a pouched product, the mixture optionally being in a free-flowing particulate form. 11. The product of claim 1 , wherein the product further comprises one or more salts, one or more sweeteners, one or more binding agents, one or more humectants, one or more gums, a tobacco material, a buffer, or combinations thereof. 12. The product of claim 1 , wherein the positively charged group of the active ingredient comprises at least one amine group. 13. A method for improving binding of an active ingredient in an oral product, the method comprising: mixing an active ingredient comprising a positively charged group with a filler which is carboxylated microcrystalline cellulose such that the active ingredient is retained by the filler though bonding between the positively charged group and carboxyl groups, and such that the active ingredient that is so-retained is configured for release therefrom when the product is present in an oral cavity. 14. The method of claim 13 , wherein the active ingredient is selected from the group consisting of a nicotine component, botanicals, stimulants, amino acids, vitamins, cannabinoids, nutraceuticals, and combinations thereof. 15. The method of claim 14 , wherein the active ingredient comprises protonated nicotine. 16. The method of claim 13 , wherein the positively charged group of the active ingredient comprises at least one amine group.

Assignees

Inventors

Classifications

  • A24B13/00Primary

    Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff (reconstituted tobacco products A24B3/14) · CPC title

  • the action of the chemical substances being delayed · CPC title

  • by aromatic compounds · CPC title

  • Plant extracts other than tobacco · CPC title

  • vitamins · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11793230B2 cover?
The disclosure provides products configured for oral use, the products including compositions comprising a filler component including negatively charged groups and an active ingredient including positively charged groups. The active ingredient can be retained by the filler component at least in part through bonding between the negatively charged groups and the positively charged groups such tha…
Who is the assignee on this patent?
Nicoventures Trading Ltd
What technology area does this patent fall under?
Primary CPC classification A24B13/00. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).